Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-637fd43f62b1505b: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-024a1683f1cf2f65: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-4b7f22edb542a8a9: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-de33380c49d3441a: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-2c13bfdb944b120d: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-96c59b21ece66a4b: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-77e2290cacbb9601: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-f18877dada6f70e0: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-82ad26c1463d475a: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-4602a1c7401ffcb4: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-637fd43f62b1505b
- pantheon_debate:pd-024a1683f1cf2f65
- pantheon_debate:pd-4b7f22edb542a8a9
- pantheon_debate:pd-de33380c49d3441a
- pantheon_debate:pd-2c13bfdb944b120d
- pantheon_debate:pd-96c59b21ece66a4b
- pantheon_debate:pd-77e2290cacbb9601
- pantheon_debate:pd-f18877dada6f70e0
- pantheon_debate:pd-82ad26c1463d475a
- pantheon_debate:pd-4602a1c7401ffcb4
Context
{"topic":"general","source_refs":["pantheon_debate:pd-637fd43f62b1505b","pantheon_debate:pd-024a1683f1cf2f65","pantheon_debate:pd-4b7f22edb542a8a9","pantheon_debate:pd-de33380c49d3441a","pantheon_debate:pd-2c13bfdb944b120d","pantheon_debate:pd-96c59b21ece66a4b","pantheon_debate:pd-77e2290cacbb9601","pantheon_debate:pd-f18877dada6f70e0","pantheon_debate:pd-82ad26c1463d475a","pantheon_debate:pd-4602a1c7401ffcb4"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10